Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Infectious Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Infectious Other
    Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Effect of High Perioperative Oxygen Fraction on Surgical Site Infection and Pulmonary Complications After Abdominal Surgery: The PROXI Randomized Clinical Trial - (JAMA)
    A randomized trial of doxycycline for Mansonella perstans infection - (N Engl J Med)
    FDA Approves Ustekinumab for Moderate to Severe Psoriasis - (DGNews)
    Once-Daily Tablet Effective in Treating Oral Yeast Infection in Patients With HIV: Presented at ICAAC - (DGDispatch)

    News archive

     Recent webcasts/CME - Infectious Other
    Biologics and Infections: Common and Rare
    Implementation of Evidence-based Strategies for Managing Antimicrobial Resistance in Health Systems

    Webcasts/CME archive

     Recent cases - Infectious Other
      Diphyllobothriasis
      Severe Anemia From Bedbugs
      Infestation by Norwegian scabies
      Late Presentation of Cutaneous Larva Migrans: A Case Report
      A Patient with Prickling Boils

      Cases archive
        




      my personal edition > infectious other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Zinc Gluconate Reduces Cold Duration And Frequency In Children

      A DGReview of :"Effectiveness of Zinc Gluconate Glycine Lozenges (Cold-Eeze) Against the Common Cold in School-Aged Subjects: A Retrospective Chart Review."
      American Journal of Therapeutics

      11/14/2002
      By Mark Greener


      Zinc gluconate glycine lozenges reduce cold duration and frequency, as well as concomitant antibiotic use, in children.

      Researchers from the Heritage Center, Provo, Utah, United States, examined the medical charts of 496 school-aged subjects before and after the introduction of zinc gluconate glycine lozenges (Cold-Eeze). Previous controlled trials suggested that the lozenges reduced cold duration.

      The authors defined a cold based on the presence of at least two specified signs or symptoms on the same day. They used patient or medical staff reports and cold medication usage to determine the cold's duration.

      Subjects taking the zinc gluconate glycine lozenges showed shorter cold duration than non-users: 7.5 and 9.0 days respectively. Further, 4.1 percent of those taking the lozenge needed concomitant antibiotics compared to 36.2 percent of non-users. Prophylaxis with the lozenge reduced the median annual number of colds from 1.3 in non-users to 0.0 among the lozenge users. All these differences reached statistical significance.

      The authors concluded that zinc gluconate glycine lozenges reduced cold duration and antibiotic use in school-aged subjects. They added that prophylactic zinc gluconate decreased the frequency of colds.
      Am J Ther 2002;9:472-5. "Effectiveness of Zinc Gluconate Glycine Lozenges (Cold-Eeze) Against the Common Cold in School-Aged Subjects: A Retrospective Chart Review."

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send